The ICLEAR service model to integrate palliative care
and respiratory medicine for patients with advanced COPD

Partners
0
Countries
0
Hospitals
0
Project Months
0

What is EU PAL-COPD?

EU PAL-COPD, a five-year research project funded by Horizon Europe, aims to advance the integration of palliative care in the treatment routine of people with advanced Chronic Obstructive Pulmonary Disease (COPD) in different healthcare systems in Europe. 

The project is dedicated to enhancing palliative and end-of-life care for those living with advanced COPD. Through the implementation of a highly innovative non-pharmacological service model called ICLEAR-EU in different healthcare systems in Europe, the goal is to improve not only medical care and physical well-being, but also prioritise a patient-centred and family-centred approach with advance care planning and shared decision-making. In order to successfully implement this palliative care service model into respiratory medicine, the project’s consortium will conduct a clinical trial in 18 hospitals across six European countries. This is the first large-scale international trial systematically integrating palliative care into respiratory care. The ambition of  EU PAL-COPD is to improve end-of-life care and well-being of life for millions of COPD patients and their families.

image depicting an ill woman sleeping with a worried man sitting next to her

The EU PAL-COPD consortium aims to develop and implement a highly innovative non-pharmacological service model called ICLEAR-EU in different healthcare systems in Europe.

By prioritising a patient-centred and family-centred approach the EU PAL-COPD solution will empower patients as active partners in shared decision-making process. 

To implement the palliative care service model into respiratory medicine, the EU PAL-COPD consortium will conduct the first large-scale international clinical trial in 18 hospitals across 6 European countries.

Receive the latest news

Subscribe To Our Newsletter

Stay informed about latest EU PAL-COPD results and milestones.